Restatement of Previously Issued Condensed Consolidated Financial Statements - Condensed Consolidated Statements of Stockholders' Equity (Details) - USD ($) $ in Thousands		3 Months Ended
		Mar. 31, 2024		Mar. 31, 2023
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning balance		$ 169,725		$ 142,605
Net loss		$ (17,399)	[1],[2],[3]	(10,812)
Options exercised, shares		48,750
Options exercised		$ 298		1,622
Restricted stock vested		(400)
Foreign currency translation		(1,097)		(99)
Employee stock purchase plan		80		122
Stock-based compensation		3,088		3,182
Ending balance		$ 154,295		$ 205,069
Common Stock
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning balance, shares		82,825,455		77,770,588
Beginning balance		$ 827		$ 776
Options exercised, shares		48,750		223,785
Options exercised				$ 2
Restricted stock vested, Shares		71,206
Restricted stock vested		$ 1
Ending balance, shares		82,945,411		82,306,873
Ending balance		$ 828		$ 821
Additional Paid-in-Capital
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning balance		298,394		213,956
Options exercised		298		1,620
Restricted stock vested		(401)
Employee stock purchase plan		80		122
Stock-based compensation		3,088		3,182
Ending balance		301,459		287,286
Accumulated Deficit
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning balance		(123,646)		(66,112)
Net loss		(17,399)		(10,812)
Ending balance		(141,045)		(76,924)
Other Comprehensive Loss
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning balance		132		(33)
Foreign currency translation		(1,097)		(99)
Ending balance		(965)		(132)
Treasury stock
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning balance		(5,982)		(5,982)
Ending balance		(5,982)		$ (5,982)
As Previously Reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning balance		177,741
Net loss		(15,234)
Options exercised		298
Restricted stock vested		(400)
Foreign currency translation		(1,097)
Employee stock purchase plan		80
Stock-based compensation		3,088
Ending balance		$ 164,476
As Previously Reported | Common Stock
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning balance, shares		82,825,455
Beginning balance		$ 827
Options exercised, shares		48,750
Restricted stock vested, Shares		71,206
Restricted stock vested		$ 1
Ending balance, shares		82,945,411
Ending balance		$ 828
As Previously Reported | Additional Paid-in-Capital
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning balance		298,394
Options exercised		298
Restricted stock vested		(401)
Employee stock purchase plan		80
Stock-based compensation		3,088
Ending balance		301,459
As Previously Reported | Accumulated Deficit
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning balance		(115,630)
Net loss		(15,234)
Ending balance		(130,864)
As Previously Reported | Other Comprehensive Loss
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning balance		132
Foreign currency translation		(1,097)
Ending balance		(965)
As Previously Reported | Treasury stock
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning balance		(5,982)
Ending balance		(5,982)
Adjustments
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning balance	[4]	(8,016)
Net loss	[1],[2],[3]	(2,165)
Ending balance		(10,181)
Adjustments | Accumulated Deficit
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning balance	[4]	(8,016)
Net loss	[1],[2],[3]	(2,165)
Ending balance		$ (10,181)

[1] Trade Receivable Reserve - The correction of the misstatement resulted in an increase to Selling, general and administrative of $567 for the three-months ended March 31, 2024.

[2] Income Tax Adjustment - The correction of the misstatement resulted in a decrease to Income tax expense (benefit) of $58 for the three-months ended March 31, 2024.

[3] Inventory Treatment - The correction of the misstatement resulted in an increase to Cost of goods sold of $1,656 for the three-months ended March 31, 2024.

[4] Inventory Treatment - The correction of the misstatement resulted in a decrease to Inventories, net and an increase to Accumulated deficit of $9,672, including an increase to the beginning balance of Accumulated deficit of $8,016 for the three-months ended March 31, 2024.